Ethosuximide-d3
Modify Date: 2024-01-10 02:35:03
Ethosuximide-d3 structure
|
Common Name | Ethosuximide-d3 | ||
|---|---|---|---|---|
| CAS Number | 1189703-33-0 | Molecular Weight | 144.18600 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C7H8D3NO2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Ethosuximide-d3Ethosuximide-d3 is the deuterium labeled Ethosuximide. Ethosuximide, a widely prescribed anti-epileptic drug, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel[1][2]. |
| Name | 3-methyl-3-(2,2,2-trideuterioethyl)pyrrolidine-2,5-dione |
|---|---|
| Synonym | More Synonyms |
| Description | Ethosuximide-d3 is the deuterium labeled Ethosuximide. Ethosuximide, a widely prescribed anti-epileptic drug, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C7H8D3NO2 |
|---|---|
| Molecular Weight | 144.18600 |
| Exact Mass | 144.09800 |
| PSA | 49.66000 |
| LogP | 0.72510 |
| Succimitin-d3 |
| Simatin-d3 |
| Etosuximid-d3 |
| Capitus-d3 |
| Atysmal-d3 |
| Ethosuximide-d3 |
| Succimal-d3 |
| Suxilep-d3 |
| Emeside-d3 |